Filing Flows

Filing Flows › Comparisons › MLSS vs AVR

Milestone Scientific vs Anteris Technologies Global: MLSS and AVR compared

Milestone Scientific is the larger company: $2.8M of revenue in its latest quarter (Q2 2026) against $1.0M for Anteris Technologies Global (Q2 2026). Anteris Technologies Global is growing faster (+63% against +22% a year earlier).

Milestone Scientific vs Anteris Technologies Global, latest quarterMilestone Scientific vs Anteris Technologies Global, latest quarterMilestone Scientific (MLSS)Anteris Technologies Global (AVR)Revenue$2.8M$1.0MRevenue growth, Y/Y+22%+63%Operating margin-37.4%n/m

Where the money goes: MLSS and AVR

Milestone Scientific (MLSS) · Q2 2026

Milestone Scientific, Q2 2026: revenue $2.8M (+22% year over year), operating margin -37.4%, net loss $1.1M, operating cash flow −$585K. The chart follows the revenue to costs, profit and cash.

Anteris Technologies Global (AVR) · Q2 2026

Anteris Technologies Global, Q2 2026: revenue $1.0M (+63% year over year), net loss $28.8M, operating cash flow −$20.8M. The chart follows the revenue to costs, profit and cash.

Milestone Scientific (MLSS)Anteris Technologies Global (AVR)
Latest quarterQ2 2026Q2 2026
Revenue$2.8M$1.0M
Revenue growth, Y/Y+22%+63%
Operating margin-37.4%n/m
Net earnings−$1.1M−$28.8M
Net margin-37.3%—
Operating cash flow−$585K−$20.8M

Questions

Which is bigger, Milestone Scientific or Anteris Technologies Global?

Milestone Scientific is the larger company: $2.8M of revenue in its latest quarter (Q2 2026) against $1.0M for Anteris Technologies Global (Q2 2026).

Is Milestone Scientific or Anteris Technologies Global growing faster?

Anteris Technologies Global is growing faster (+63% against +22% a year earlier).

More: Milestone Scientific earnings · how Milestone Scientific makes money · Anteris Technologies Global earnings · how Anteris Technologies Global makes money

From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Aug 11, 2026). Fiscal quarters can end on different dates. Not investment advice.